Janssen Research articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/10/25 15:42
2014/10/25 15:42
16h
... is the first published indication that blocking RIPK2 might be efficacious in inflammatory disease," said senior author Derek Abbott, MD, PhD, associate professor of pathology, Case Western...
2014/10/25 15:42
2014/10/25 15:42
Latest videos
2014/10/22 13:44
2014/10/22 13:44
3d
REGROWING RETINAS: By culturing mouse embryonic stem cells, researchers can grow nascent retinas containing photoreceptor precursors that express the visual pigment rhodopsin (green) and the...
2014/10/20 14:08
2014/10/20 14:08
5d
Janssen Research & Development, LLC ("Janssen") today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA® (ibrutinib) to the U.S. Food and Drug Administration (FDA)...
2014/09/30 11:08
2014/09/30 11:08
25d
Outstanding scientists honored for achievements in psychiatric research at 27th annual dinner The Brain & Behavior Research Foundation will honor eight scientists with its 2014 Outstanding...
2014/09/30 08:08
2014/09/30 08:08
26d
... with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC). The Janssen Research & Development, LLC ("Janssen")-sponsored registration study demonstrated a 19 percent...
2014/09/29 01:17
2014/09/29 01:17
27d
ZYTIGAMD en association avec la prednisone a entraîné une prolongation statistiquement significative de la survie globale chez des hommes atteints du cancer de la prostate métastatique résistant à la...
2014/09/28 09:17
2014/09/28 09:17
27d
BEERSE, Belgien--(BUSINESS WIRE)--Wie Janssen-Cilag International NV heute bekannt gab, zeigen Daten der abschließenden Auswertung der Phase-3-Studie COU-AA-302, dass ZYTIGA® (Abirateronazetat) in...
2014/10/25 15:42
2014/10/25 15:42
Latest from Twitter